关注
Liang Ouyang(欧阳亮)
Liang Ouyang(欧阳亮)
在 scu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
L Ouyang, Z Shi, S Zhao, FT Wang, TT Zhou, B Liu, JK Bao
Cell proliferation 45 (6), 487-498, 2012
18052012
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
L Fu, M Tian, X Li, J Li, J Huang, L Ouyang, Y Zhang, B Liu
Oncotarget 6 (8), 5501, 2015
2412015
Plant natural compounds: targeting pathways of autophagy as anti‐cancer therapeutic agents
X Zhang, LX Chen, L Ouyang, Y Cheng, B Liu
Cell proliferation 45 (5), 466-476, 2012
1962012
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Y Wang, J He, M Liao, M Hu, W Li, H Ouyang, X Wang, T Ye, Y Zhang, ...
European journal of medicinal chemistry 161, 48-77, 2019
1872019
Targeting autophagy-related protein kinases for potential therapeutic purpose
H Xiang, J Zhang, C Lin, L Zhang, B Liu, L Ouyang
Acta Pharmaceutica Sinica B 10 (4), 569-581, 2020
1732020
Plant natural products: from traditional compounds to new emerging drugs in cancer therapy
L Ouyang, Y Luo, M Tian, SY Zhang, R Lu, JH Wang, R Kasimu, X Li
Cell proliferation 47 (6), 506-515, 2014
1582014
Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, ...
Nano letters 19 (11), 8318-8332, 2019
1482019
Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy
QL Jiang, S Zhang, M Tian, SY Zhang, T Xie, DY Chen, YJ Chen, J He, ...
Cell proliferation 48 (1), 17-28, 2015
1372015
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo
L Zhang, L Fu, S Zhang, J Zhang, Y Zhao, Y Zheng, G He, S Yang, ...
Chemical science 8 (4), 2687-2701, 2017
1362017
Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer
Y Shu, W Zhang, Q Hou, L Zhao, S Zhang, J Zhou, X Song, Y Zhang, ...
Nature communications 9 (1), 2447, 2018
1202018
Tumor microenvironment‐responsive dual drug dimer‐loaded pegylated bilirubin nanoparticles for improved drug delivery and enhanced immune‐chemotherapy of breast cancer
X Yang, C Hu, F Tong, R Liu, Y Zhou, L Qin, L Ouyang, H Gao
Advanced Functional Materials 29 (32), 1901896, 2019
1062019
Review of natural product databases
T Xie, S Song, S Li, L Ouyang, L Xia, J Huang
Cell proliferation 48 (4), 398-404, 2015
1012015
The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy
Y Liu, X Wang, G Wang, Y Yang, Y Yuan, L Ouyang
European journal of medicinal chemistry 176, 92-104, 2019
1002019
Discovery of a small-molecule bromodomain-containing protein 4 (BRD4) inhibitor that induces AMP-activated protein kinase-modulated autophagy-associated cell death in breast cancer
L Ouyang, L Zhang, J Liu, L Fu, D Yao, Y Zhao, S Zhang, G Wang, G He, ...
Journal of medicinal chemistry 60 (24), 9990-10012, 2017
992017
New techniques and strategies in drug discovery
J Du, J Guo, D Kang, Z Li, G Wang, J Wu, Z Zhang, H Fang, X Hou, ...
Chinese Chemical Letters 31 (7), 1695-1708, 2020
962020
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs
J Zhang, X Jiang, Y Jiang, M Guo, S Zhang, J Li, J He, J Liu, J Wang, ...
European journal of medicinal chemistry 108, 495-504, 2016
862016
Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy
L Zhang, J Li, L Ouyang, B Liu, Y Cheng
Cancer letters 373 (1), 19-26, 2016
852016
Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy
W Shuai, G Wang, Y Zhang, F Bu, S Zhang, DD Miller, W Li, L Ouyang, ...
Journal of Medicinal Chemistry 64 (12), 7963-7990, 2021
822021
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
T Jiang, G Wang, Y Liu, L Feng, M Wang, J Liu, Y Chen, L Ouyang
Acta Pharmaceutica Sinica B 11 (2), 355-372, 2021
812021
Targeting bromodomain and extraterminal proteins for drug discovery: from current progress to technological development
P Tang, J Zhang, J Liu, CM Chiang, L Ouyang
Journal of medicinal chemistry 64 (5), 2419-2435, 2021
802021
系统目前无法执行此操作,请稍后再试。
文章 1–20